Basic Search  |  Summaries  |  Advanced Search

Violation Tracker Individual Record

Company: Warner Chilcott
Current Parent Company: AbbVie
Parent at the Time of the Penalty Announcement:  subscribe to see this data field
Recap of Ownership Changes:  subscribe to see this data field
Penalty: $8,000,000
Year: 2015
Date: January 28, 2015
Offense Group: competition-related offenses
Primary Offense: price-fixing or anti-competitive practices
Violation Description: Warner Chilcott agreed to pay $8 million to settle litigation alleging it blocked the introduction of a generic version of the acne drug Doryx.
Level of Government: federal
Action Type: private litigation
Court: Eastern District of Pennsylvania
Civil or Criminal Case: civil
Case ID: 2:12-cv-03824
Case Name: Mylan Pharmaceuticals Inc. v. Warner Chilcott Public Limited Company et al
Private Lawsuit Resolution Type: settlement
HQ Country of Current Parent: USA
HQ State of Current Parent: Illinois
Ownership Structure of Current Parent: publicly traded
Major Industry of Current Parent: pharmaceuticals
Specific Industry of Current Parent: pharmaceuticals
Source of Data: (click here)
Link to PACER Case Docket (must be logged in): (click here)
Link to Archived Court Document:  subscribe to see this data field
Source Notes: If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.
Current parent company note: Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.